Wee1 inhibitors are a promising new cancer treatment, but serious side effects threaten their adoption in the clinic. Now, ...
A peer-reviewed review proposes that chronic DNA damage response signaling may connect senescence, inflammation and other ...
The ATR–ATRIP kinase complex safeguards genome integrity by coordinating cellular responses to DNA damage and replication stress. Two recent cryo-EM studies resolve the structural basis of ATR–ATRIP ...
A routine blood draw taken in early pregnancy could one day reveal which women are heading toward gestational diabetes, if a ...
Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a ...
Global DNA Polymerase Market size is expected to be worth around US$ 717.0 Million by 2034 from US$ 389.2 Million in 2024.
An AI platform can identify and rank drug combinations to overcome cancer treatment resistance. The system successfully ...
Experts found individuals with longer repeats of a specific gene sequence in their DNA were more likely to have the disease.
Publication of first ever head-to-head comparison of gut microbiome changes associated with novel oral preclinical PolC (pol IIIC*) inhibitors to linezolid ...
Sofetabart mipitecan (Sofe-M) in combination with bevacizumab demonstrated a 79% confirmed objective response rate and 100% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results